Valeant Said to Offer Lenders More Money to Relax Loan Terms

Valeant Pharmaceuticals International Inc. is offering its lenders a one-time fee and extra interest on its loans in exchange for waiving a default caused by its delayed earnings filing and loosening some restrictions on its debt load.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.